First Foundation Advisors Shockwave Medical, Inc. Transaction History

First Foundation Advisors

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$160.99 - $215.69 $13,201 - $17,686	-82 Reduced 7.58%	1,000 $190,000
Q3 2023 Nov 15, 2023	SELL	$194.33 - $283.97 $10,105 - $14,766	-52 Reduced 4.59%	1,082 $215,000
Q2 2023 Aug 14, 2023	BUY	$223.05 - $302.68 $6,691 - $9,080	30 Added 2.72%	1,134 $323,000
Q1 2023 May 12, 2023	SELL	$175.41 - $217.92 $1,403 - $1,743	-8 Reduced 0.72%	1,104 $239,000
Q4 2022 Feb 14, 2023	SELL	$204.38 - $296.82 $13,080 - $18,996	-64 Reduced 5.44%	1,112 $228,000
Q3 2022 Nov 10, 2022	BUY	$195.21 - $310.53 $2,342 - $3,726	12 Added 1.03%	1,176 $327,000
Q2 2022 Aug 12, 2022	BUY	$115.91 - $214.48 $134,919 - $249,654	1,164 New	1,164 $223,000

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of First Foundation Advisors, based on Form 13F filings with the SEC.

Stay updated on First Foundation Advisors with notifications on news.